Xuzhou

The trials here

What the trial at this site is about, from its registry record.

Conditions

• Metastatic breast cancer

Running trials

• Active, not recruiting

  A Study of DB-1303/BNT323 vs Investigator's Choice Chemotherapy in HER2-Low, Hormone Receptor Positive Metastatic Breast Cancer (DYNASTY-Breast02)

  NCT06018337· Phase 3· DualityBio Inc.· Source